FI20080333A0 - Influenza virus nucleic acids and peptides - Google Patents

Influenza virus nucleic acids and peptides

Info

Publication number
FI20080333A0
FI20080333A0 FI20080333A FI20080333A FI20080333A0 FI 20080333 A0 FI20080333 A0 FI 20080333A0 FI 20080333 A FI20080333 A FI 20080333A FI 20080333 A FI20080333 A FI 20080333A FI 20080333 A0 FI20080333 A0 FI 20080333A0
Authority
FI
Finland
Prior art keywords
peptides
nucleic acids
influenza virus
virus nucleic
influenza
Prior art date
Application number
FI20080333A
Other languages
Finnish (fi)
Swedish (sv)
Inventor
Jari Natunen
Jukka Hiltunen
Ritva Niemelae
Jari Helin
Olli Aitio
Original Assignee
Glykos Finland Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glykos Finland Oy filed Critical Glykos Finland Oy
Priority to FI20080333A priority Critical patent/FI20080333A0/en
Publication of FI20080333A0 publication Critical patent/FI20080333A0/en
Priority to PCT/FI2009/050357 priority patent/WO2009133249A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FI20080333A 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides FI20080333A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20080333A FI20080333A0 (en) 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides
PCT/FI2009/050357 WO2009133249A1 (en) 2008-05-02 2009-05-04 Peptide vaccine for influenza virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20080333A FI20080333A0 (en) 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides

Publications (1)

Publication Number Publication Date
FI20080333A0 true FI20080333A0 (en) 2008-05-02

Family

ID=39523003

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20080333A FI20080333A0 (en) 2008-05-02 2008-05-02 Influenza virus nucleic acids and peptides

Country Status (2)

Country Link
FI (1) FI20080333A0 (en)
WO (1) WO2009133249A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DE00411A (en) * 2012-02-14 2015-06-05 Council Scient Ind Res
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN113924147A (en) 2019-03-25 2022-01-11 威特拉公司 Compositions and methods for treating and preventing influenza
CN115297882A (en) * 2020-03-16 2022-11-04 横向知识产权私人有限公司 Composition for treating respiratory tract infection and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) * 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
FI20060200A0 (en) * 2005-04-20 2006-02-27 Glykos Finland Oy Method for analyzing the specificity of sialic acid binding of human influenza virus
KR20080027777A (en) * 2005-06-01 2008-03-28 배리에이션 바이오테크놀로지스 아이엔씨. Peptide-based influenza vaccine formulation
EP2069376A4 (en) * 2006-07-21 2013-10-16 Pharmexa Inc Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
FI20060946A0 (en) * 2006-10-26 2006-10-26 Glykos Finland Oy Influenza virus nucleic acids and peptides

Also Published As

Publication number Publication date
WO2009133249A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
FI20060946A0 (en) Influenza virus nucleic acids and peptides
ATE555109T1 (en) HEPATITIS C VIRUS INHIBITORS
BRPI0907733A2 (en) Hepatitis C virus inhibitors
CY2015012I1 (en) HEPATITIS C VIRUS INHIBITORS
BRPI0915142A2 (en) polypeptides, nucleic acid and uses thereof
DK2478916T3 (en) Influenza vaccines containing hemagglutinin and matrix proteins
BRPI0915487A2 (en) nfluenza hemagglutin and neuraminidase variants
BRPI0912198A2 (en) anti-fn14 antibodies and uses thereof
DK2242752T3 (en) Imidazolyl-biphenylimidazoles as hepatitis C virus inhibitors
IL213189A0 (en) Recombinant avian influenza vaccine and uses thereof
BRPI1014084A2 (en) hepatitis c virus inhibitors
BRPI1013393A2 (en) hepatitis c virus inhibitors
BRPI1007836A2 (en) Hepatitis C Virus Inhibitors
BRPI1008846A2 (en) hepatitis c virus inhibitors
DK2043682T3 (en) INFLUENZA VACCINE
BRPI0821034A2 (en) Modified Influenza Virus
CR10571A (en) RECOMBINING VIRIC VACCINE
EP2118323A4 (en) Detection of influenza virus
BR112012004731A2 (en) wnt10-derived peptides and their use
EP2265646A4 (en) Reagents and methods for detecting influenza virus proteins
ZA200809056B (en) Influenza virus vaccine
FI20090030A0 (en) Oncolytic virus
FI20080333A0 (en) Influenza virus nucleic acids and peptides
BRPI0923034A2 (en) hepatitis c virus combination therapy
EP2368899B8 (en) Avian influenza vaccine